

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of T-helper cell differentiation (GO:0045623) | 9.46546530 |
| 2 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 9.46546530 |
| 3 | protein K11-linked deubiquitination (GO:0035871) | 9.39704577 |
| 4 | negative regulation of type 2 immune response (GO:0002829) | 8.81480698 |
| 5 | regulation of T-helper 2 cell differentiation (GO:0045628) | 8.78115214 |
| 6 | positive regulation of RNA splicing (GO:0033120) | 8.77490763 |
| 7 | regulation of T-helper 1 cell differentiation (GO:0045625) | 8.52219163 |
| 8 | seminiferous tubule development (GO:0072520) | 8.38315033 |
| 9 | cAMP biosynthetic process (GO:0006171) | 8.27031084 |
| 10 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 7.54519716 |
| 11 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 7.26603650 |
| 12 | enteric nervous system development (GO:0048484) | 7.06166378 |
| 13 | positive regulation of mitochondrial fission (GO:0090141) | 6.93705018 |
| 14 | righting reflex (GO:0060013) | 6.88867596 |
| 15 | synaptic transmission, dopaminergic (GO:0001963) | 6.88219674 |
| 16 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 6.83531546 |
| 17 | regulation of protein sumoylation (GO:0033233) | 6.68317640 |
| 18 | synaptic vesicle maturation (GO:0016188) | 6.43359202 |
| 19 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.33275760 |
| 20 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.13927769 |
| 21 | locomotory exploration behavior (GO:0035641) | 6.03150811 |
| 22 | vocalization behavior (GO:0071625) | 6.00723572 |
| 23 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.95426579 |
| 24 | neuronal ion channel clustering (GO:0045161) | 5.80954712 |
| 25 | heterotypic cell-cell adhesion (GO:0034113) | 5.57103224 |
| 26 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.56295289 |
| 27 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.41232439 |
| 28 | chemosensory behavior (GO:0007635) | 5.36375093 |
| 29 | detection of chemical stimulus (GO:0009593) | 5.31881996 |
| 30 | synaptic vesicle exocytosis (GO:0016079) | 5.25796982 |
| 31 | protein localization to synapse (GO:0035418) | 5.24238873 |
| 32 | glutamate secretion (GO:0014047) | 5.21312398 |
| 33 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.18920387 |
| 34 | positive regulation of T-helper 1 type immune response (GO:0002827) | 5.16246613 |
| 35 | endothelial cell differentiation (GO:0045446) | 5.09816384 |
| 36 | regulation of mitochondrial fission (GO:0090140) | 5.06056948 |
| 37 | icosanoid secretion (GO:0032309) | 5.05780672 |
| 38 | arachidonic acid secretion (GO:0050482) | 5.05780672 |
| 39 | neuron cell-cell adhesion (GO:0007158) | 5.05666476 |
| 40 | exploration behavior (GO:0035640) | 5.03183574 |
| 41 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.97967448 |
| 42 | positive regulation of T-helper cell differentiation (GO:0045624) | 4.89858414 |
| 43 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.77485348 |
| 44 | layer formation in cerebral cortex (GO:0021819) | 4.76896084 |
| 45 | response to dietary excess (GO:0002021) | 4.75178521 |
| 46 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 4.63121887 |
| 47 | hepatocyte apoptotic process (GO:0097284) | 4.61652340 |
| 48 | dendritic spine morphogenesis (GO:0060997) | 4.60352752 |
| 49 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.59676593 |
| 50 | gamma-aminobutyric acid transport (GO:0015812) | 4.55863988 |
| 51 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.53896394 |
| 52 | ATP hydrolysis coupled proton transport (GO:0015991) | 4.50249798 |
| 53 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 4.50249798 |
| 54 | cellular response to glucagon stimulus (GO:0071377) | 4.48916642 |
| 55 | regulation of synaptic vesicle transport (GO:1902803) | 4.40872334 |
| 56 | synaptic transmission, glutamatergic (GO:0035249) | 4.39152625 |
| 57 | regulation of synapse structural plasticity (GO:0051823) | 4.34566908 |
| 58 | drug transmembrane transport (GO:0006855) | 4.33904143 |
| 59 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.33617491 |
| 60 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 4.33150852 |
| 61 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.32565900 |
| 62 | postsynaptic membrane organization (GO:0001941) | 4.30480547 |
| 63 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 4.30130219 |
| 64 | neurotransmitter secretion (GO:0007269) | 4.25846380 |
| 65 | cyclic purine nucleotide metabolic process (GO:0052652) | 4.24317849 |
| 66 | proline transport (GO:0015824) | 4.23389677 |
| 67 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 4.22951849 |
| 68 | cAMP metabolic process (GO:0046058) | 4.17171653 |
| 69 | glutamate receptor signaling pathway (GO:0007215) | 4.16116576 |
| 70 | icosanoid transport (GO:0071715) | 4.12951428 |
| 71 | fatty acid derivative transport (GO:1901571) | 4.12951428 |
| 72 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.11280351 |
| 73 | positive regulation of membrane potential (GO:0045838) | 4.10402088 |
| 74 | cyclic nucleotide biosynthetic process (GO:0009190) | 4.07596499 |
| 75 | water transport (GO:0006833) | 4.05346242 |
| 76 | retina layer formation (GO:0010842) | 4.01018512 |
| 77 | regulation of cAMP-mediated signaling (GO:0043949) | 3.99410755 |
| 78 | positive regulation of synapse maturation (GO:0090129) | 3.99121883 |
| 79 | neuron recognition (GO:0008038) | 3.98351329 |
| 80 | neural tube formation (GO:0001841) | 3.97921125 |
| 81 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.91435501 |
| 82 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.90060996 |
| 83 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.88242266 |
| 84 | neuron-neuron synaptic transmission (GO:0007270) | 3.88086141 |
| 85 | presynaptic membrane assembly (GO:0097105) | 3.87035031 |
| 86 | long-term memory (GO:0007616) | 3.83268810 |
| 87 | axonal fasciculation (GO:0007413) | 3.82818335 |
| 88 | nephron epithelium morphogenesis (GO:0072088) | 3.80623209 |
| 89 | nephron tubule morphogenesis (GO:0072078) | 3.80623209 |
| 90 | neuromuscular process controlling posture (GO:0050884) | 3.79101950 |
| 91 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.78459057 |
| 92 | neurofilament cytoskeleton organization (GO:0060052) | 3.77037956 |
| 93 | mitochondrial fusion (GO:0008053) | 3.74917545 |
| 94 | dendrite morphogenesis (GO:0048813) | 3.74452063 |
| 95 | cellular potassium ion homeostasis (GO:0030007) | 3.73486691 |
| 96 | neuronal action potential propagation (GO:0019227) | 3.70577448 |
| 97 | regulation of postsynaptic membrane potential (GO:0060078) | 3.70506306 |
| 98 | hyaluronan catabolic process (GO:0030214) | 3.67501797 |
| 99 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.66855966 |
| 100 | negative regulation of actin filament bundle assembly (GO:0032232) | 3.65458961 |
| 101 | positive regulation of protein targeting to membrane (GO:0090314) | 3.65350641 |
| 102 | monoamine transport (GO:0015844) | 3.64202892 |
| 103 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.61038883 |
| 104 | sodium ion export (GO:0071436) | 3.60877240 |
| 105 | regulation of T-helper 1 type immune response (GO:0002825) | 3.60208910 |
| 106 | embryonic digestive tract morphogenesis (GO:0048557) | 3.57789551 |
| 107 | fluid transport (GO:0042044) | 3.57445288 |
| 108 | regulation of type 2 immune response (GO:0002828) | 3.56600148 |
| 109 | regulation of synaptic plasticity (GO:0048167) | 3.56011949 |
| 110 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.50435921 |
| 111 | activation of protein kinase A activity (GO:0034199) | 3.49411555 |
| 112 | regulation of neurotransmitter secretion (GO:0046928) | 3.49023108 |
| 113 | cellular potassium ion transport (GO:0071804) | 3.48687883 |
| 114 | potassium ion transmembrane transport (GO:0071805) | 3.48687883 |
| 115 | neuromuscular process controlling balance (GO:0050885) | 3.47911661 |
| 116 | presynaptic membrane organization (GO:0097090) | 3.45251783 |
| 117 | regulation of T-helper cell differentiation (GO:0045622) | 3.45026197 |
| 118 | neurotransmitter transport (GO:0006836) | 3.42967534 |
| 119 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.40984013 |
| 120 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.40609948 |
| 121 | cell communication by electrical coupling (GO:0010644) | 3.40445895 |
| 122 | synaptic vesicle endocytosis (GO:0048488) | 3.39021387 |
| 123 | regulation of dendritic spine development (GO:0060998) | 3.37994266 |
| 124 | transmission of nerve impulse (GO:0019226) | 3.37764927 |
| 125 | cellular response to ATP (GO:0071318) | 3.35845764 |
| 126 | response to glucagon (GO:0033762) | 3.35055708 |
| 127 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.34066508 |
| 128 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193) | 3.32883155 |
| 129 | dendritic spine organization (GO:0097061) | 3.29403384 |
| 130 | vesicle transport along microtubule (GO:0047496) | 3.29358722 |
| 131 | cell migration in hindbrain (GO:0021535) | 3.28865990 |
| 132 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.27425760 |
| 133 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.26734868 |
| 134 | negative regulation of astrocyte differentiation (GO:0048712) | 3.25795613 |
| 135 | innervation (GO:0060384) | 3.24784750 |
| 136 | positive regulation of dendritic spine development (GO:0060999) | 3.24421907 |
| 137 | response to auditory stimulus (GO:0010996) | 3.24316843 |
| 138 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.24270939 |
| 139 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.23161338 |
| 140 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.22550627 |
| 141 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.21990481 |
| 142 | cellular zinc ion homeostasis (GO:0006882) | 3.21443810 |
| 143 | auditory behavior (GO:0031223) | 3.21060356 |
| 144 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.20893928 |
| 145 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.20893928 |
| 146 | intraspecies interaction between organisms (GO:0051703) | 3.19810889 |
| 147 | social behavior (GO:0035176) | 3.19810889 |
| 148 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.19312961 |
| 149 | organelle transport along microtubule (GO:0072384) | 3.18465414 |
| 150 | L-amino acid import (GO:0043092) | 3.18394640 |
| 151 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.17134267 |
| 152 | regulation of vesicle fusion (GO:0031338) | 3.17083958 |
| 153 | pre-miRNA processing (GO:0031054) | 3.16030158 |
| 154 | regulation of neurotransmitter levels (GO:0001505) | 3.11431224 |
| 155 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.11280896 |
| 156 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.10052900 |
| 157 | synapse assembly (GO:0007416) | 3.09617457 |
| 158 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 3.09568276 |
| 159 | long-term synaptic potentiation (GO:0060291) | 3.08361441 |
| 160 | regulation of neurotransmitter transport (GO:0051588) | 3.07117705 |
| 161 | cerebellar Purkinje cell layer development (GO:0021680) | 3.06799069 |
| 162 | adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189) | 3.06720939 |
| 163 | reflex (GO:0060004) | 3.06429785 |
| 164 | membrane hyperpolarization (GO:0060081) | 3.06368483 |
| 165 | regulation of protein targeting to membrane (GO:0090313) | 3.05950543 |
| 166 | activation of phospholipase C activity (GO:0007202) | 3.05633785 |
| 167 | membrane depolarization (GO:0051899) | 3.05390217 |
| 168 | learning (GO:0007612) | 3.04340920 |
| 169 | positive regulation of neurotransmitter transport (GO:0051590) | 3.03704991 |
| 170 | regulation of synapse maturation (GO:0090128) | 3.03444328 |
| 171 | behavioral fear response (GO:0001662) | 3.00759657 |
| 172 | behavioral defense response (GO:0002209) | 3.00759657 |
| 173 | leukotriene biosynthetic process (GO:0019370) | 2.98570644 |
| 174 | renal tubule morphogenesis (GO:0061333) | 2.98369716 |
| 175 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.96706800 |
| 176 | regulation of synaptic transmission (GO:0050804) | 2.96182598 |
| 177 | regulation of ARF protein signal transduction (GO:0032012) | 2.94874598 |
| 178 | glycine transport (GO:0015816) | 2.94670852 |
| 179 | response to histamine (GO:0034776) | 2.94143690 |
| 180 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.93078627 |
| 181 | positive regulation of synaptic transmission (GO:0050806) | 2.90906151 |
| 182 | neuromuscular process (GO:0050905) | 2.90001991 |
| 183 | membrane depolarization during action potential (GO:0086010) | 2.88749084 |
| 184 | tooth mineralization (GO:0034505) | 12.1282119 |
| 185 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 11.7392109 |
| 186 | positive regulation of protein sumoylation (GO:0033235) | 10.7267259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 9.11490846 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 6.10830037 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.01352223 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.01919700 |
| 5 | VDR_22108803_ChIP-Seq_LS180_Human | 3.36824682 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.30130039 |
| 7 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.14054719 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.10092314 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.05025348 |
| 10 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.89616974 |
| 11 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.78722350 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.73035416 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.73035416 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.69102129 |
| 15 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.66478326 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.58748828 |
| 17 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.58140434 |
| 18 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.55608697 |
| 19 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.55475271 |
| 20 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.55451252 |
| 21 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.53437775 |
| 22 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.40185423 |
| 23 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.39739082 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.39206963 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.37665157 |
| 26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.29098837 |
| 27 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.28488354 |
| 28 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.23642092 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.20399320 |
| 30 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.17541209 |
| 31 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.02739927 |
| 32 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.00481494 |
| 33 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.95411435 |
| 34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.87509932 |
| 35 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.68685469 |
| 36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.63558874 |
| 37 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.57255537 |
| 38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.55509125 |
| 39 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.51694942 |
| 40 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.51586419 |
| 41 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.50687504 |
| 42 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.47368674 |
| 43 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.45925507 |
| 44 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.43179306 |
| 45 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.42105814 |
| 46 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.41528930 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.39020220 |
| 48 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.33613367 |
| 49 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.31929282 |
| 50 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.29823669 |
| 51 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.27645632 |
| 52 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.26306613 |
| 53 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.26127908 |
| 54 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.24635199 |
| 55 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.24224626 |
| 56 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.23824509 |
| 57 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.23121739 |
| 58 | KDM2B_26808549_Chip-Seq_K562_Human | 1.22316181 |
| 59 | AR_25329375_ChIP-Seq_VCAP_Human | 1.22140543 |
| 60 | P300_19829295_ChIP-Seq_ESCs_Human | 1.21535804 |
| 61 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.21132476 |
| 62 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.20947427 |
| 63 | AR_19668381_ChIP-Seq_PC3_Human | 1.20586031 |
| 64 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.19923374 |
| 65 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.19897194 |
| 66 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.17491882 |
| 67 | RXR_22108803_ChIP-Seq_LS180_Human | 1.17192790 |
| 68 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.16800492 |
| 69 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.16422257 |
| 70 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.15431686 |
| 71 | STAT3_23295773_ChIP-Seq_U87_Human | 1.13691105 |
| 72 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.12337701 |
| 73 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.12188613 |
| 74 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.11041953 |
| 75 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09612043 |
| 76 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07615269 |
| 77 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07201103 |
| 78 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.06227196 |
| 79 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.04928796 |
| 80 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03186821 |
| 81 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.01670260 |
| 82 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.00547337 |
| 83 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00402399 |
| 84 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.00341514 |
| 85 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.00198555 |
| 86 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.99142324 |
| 87 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99056387 |
| 88 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.98709628 |
| 89 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98703218 |
| 90 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98600651 |
| 91 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.98575618 |
| 92 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.98347451 |
| 93 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.97597073 |
| 94 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96674885 |
| 95 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.96003486 |
| 96 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.95943431 |
| 97 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.95739932 |
| 98 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.95605218 |
| 99 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.95143018 |
| 100 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95000738 |
| 101 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.94960045 |
| 102 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.94351293 |
| 103 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92689724 |
| 104 | TBL1_22424771_ChIP-Seq_293T_Human | 0.92544933 |
| 105 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91804277 |
| 106 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91215332 |
| 107 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89736786 |
| 108 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.89031361 |
| 109 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.88962035 |
| 110 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.88931686 |
| 111 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.88481512 |
| 112 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.88317625 |
| 113 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88317625 |
| 114 | TP53_16413492_ChIP-PET_HCT116_Human | 0.87602552 |
| 115 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.87289572 |
| 116 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.87122421 |
| 117 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.86963519 |
| 118 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.86581144 |
| 119 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.86343654 |
| 120 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.86154824 |
| 121 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.85415005 |
| 122 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.84679346 |
| 123 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.84335559 |
| 124 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.83582562 |
| 125 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.82913906 |
| 126 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.82636885 |
| 127 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.82520427 |
| 128 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.82488052 |
| 129 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.82470146 |
| 130 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.80286809 |
| 131 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.79758475 |
| 132 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.79371512 |
| 133 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.79353833 |
| 134 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.79237456 |
| 135 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.77466475 |
| 136 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.77466475 |
| 137 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.76308772 |
| 138 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.74807533 |
| 139 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.74767956 |
| 140 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.73984805 |
| 141 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.73348170 |
| 142 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.73299013 |
| 143 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.73084983 |
| 144 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.72642881 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.07713054 |
| 2 | MP0003880_abnormal_central_pattern | 4.71283383 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.23618717 |
| 4 | MP0004270_analgesia | 4.02444395 |
| 5 | MP0005423_abnormal_somatic_nervous | 3.76483100 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.45400012 |
| 7 | MP0009745_abnormal_behavioral_response | 3.29985224 |
| 8 | MP0004264_abnormal_extraembryonic_tissu | 3.14733346 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.13000706 |
| 10 | MP0002064_seizures | 3.01641365 |
| 11 | MP0002734_abnormal_mechanical_nocicepti | 2.82069691 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.74373896 |
| 13 | MP0003252_abnormal_bile_duct | 2.72592828 |
| 14 | MP0009046_muscle_twitch | 2.65275764 |
| 15 | MP0004133_heterotaxia | 2.59694534 |
| 16 | MP0001486_abnormal_startle_reflex | 2.54085733 |
| 17 | MP0002735_abnormal_chemical_nociception | 2.42395530 |
| 18 | MP0002272_abnormal_nervous_system | 2.39890734 |
| 19 | MP0002928_abnormal_bile_duct | 2.35940427 |
| 20 | MP0002736_abnormal_nociception_after | 2.34219812 |
| 21 | MP0004858_abnormal_nervous_system | 2.27791381 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 2.16747821 |
| 23 | MP0000778_abnormal_nervous_system | 2.12672025 |
| 24 | MP0001440_abnormal_grooming_behavior | 2.12401462 |
| 25 | MP0001501_abnormal_sleep_pattern | 2.11270808 |
| 26 | MP0005448_abnormal_energy_balance | 2.09095654 |
| 27 | MP0002733_abnormal_thermal_nociception | 2.08282728 |
| 28 | MP0003329_amyloid_beta_deposits | 2.08218933 |
| 29 | MP0002751_abnormal_autonomic_nervous | 2.02841525 |
| 30 | MP0005084_abnormal_gallbladder_morpholo | 10.5373669 |
| 31 | MP0001970_abnormal_pain_threshold | 1.93166806 |
| 32 | MP0002184_abnormal_innervation | 1.92036044 |
| 33 | MP0004811_abnormal_neuron_physiology | 1.91195829 |
| 34 | MP0002067_abnormal_sensory_capabilities | 1.87200215 |
| 35 | MP0008569_lethality_at_weaning | 1.79364001 |
| 36 | MP0002557_abnormal_social/conspecific_i | 1.74432444 |
| 37 | MP0001270_distended_abdomen | 1.73816276 |
| 38 | MP0002909_abnormal_adrenal_gland | 1.67672423 |
| 39 | MP0000955_abnormal_spinal_cord | 1.66883760 |
| 40 | MP0004924_abnormal_behavior | 1.65396116 |
| 41 | MP0005386_behavior/neurological_phenoty | 1.65396116 |
| 42 | MP0002822_catalepsy | 1.61345478 |
| 43 | MP0006276_abnormal_autonomic_nervous | 1.59968791 |
| 44 | MP0003879_abnormal_hair_cell | 1.59662096 |
| 45 | MP0002882_abnormal_neuron_morphology | 1.55771304 |
| 46 | MP0004885_abnormal_endolymph | 1.54781739 |
| 47 | MP0001984_abnormal_olfaction | 1.53822075 |
| 48 | MP0005551_abnormal_eye_electrophysiolog | 1.45908445 |
| 49 | MP0005379_endocrine/exocrine_gland_phen | 1.45641629 |
| 50 | MP0005646_abnormal_pituitary_gland | 1.43492064 |
| 51 | MP0002066_abnormal_motor_capabilities/c | 1.40135535 |
| 52 | MP0003633_abnormal_nervous_system | 1.36302861 |
| 53 | MP0005645_abnormal_hypothalamus_physiol | 1.36084163 |
| 54 | MP0003787_abnormal_imprinting | 1.33060156 |
| 55 | MP0005408_hypopigmentation | 1.24224920 |
| 56 | MP0003943_abnormal_hepatobiliary_system | 1.24077363 |
| 57 | MP0003121_genomic_imprinting | 1.22092774 |
| 58 | MP0005165_increased_susceptibility_to | 1.20093521 |
| 59 | MP0001502_abnormal_circadian_rhythm | 1.19543276 |
| 60 | MP0005220_abnormal_exocrine_pancreas | 1.18939711 |
| 61 | MP0002152_abnormal_brain_morphology | 1.16798556 |
| 62 | MP0003631_nervous_system_phenotype | 1.15797919 |
| 63 | MP0004142_abnormal_muscle_tone | 1.08049082 |
| 64 | MP0002229_neurodegeneration | 1.07052571 |
| 65 | MP0001529_abnormal_vocalization | 1.06626781 |
| 66 | MP0004272_abnormal_basement_membrane | 1.04773218 |
| 67 | MP0003122_maternal_imprinting | 0.98621632 |
| 68 | MP0001905_abnormal_dopamine_level | 0.97796424 |
| 69 | MP0003075_altered_response_to | 0.96743336 |
| 70 | MP0000751_myopathy | 0.96704790 |
| 71 | MP0000604_amyloidosis | 0.96685479 |
| 72 | MP0010234_abnormal_vibrissa_follicle | 0.93388811 |
| 73 | MP0003283_abnormal_digestive_organ | 0.93229836 |
| 74 | MP0002069_abnormal_eating/drinking_beha | 0.92912495 |
| 75 | MP0003634_abnormal_glial_cell | 0.92237473 |
| 76 | MP0001944_abnormal_pancreas_morphology | 0.91456559 |
| 77 | MP0001177_atelectasis | 0.90818309 |
| 78 | MP0002752_abnormal_somatic_nervous | 0.89798645 |
| 79 | MP0004510_myositis | 0.87754669 |
| 80 | MP0008961_abnormal_basal_metabolism | 0.84389685 |
| 81 | MP0003690_abnormal_glial_cell | 0.84278496 |
| 82 | MP0003632_abnormal_nervous_system | 0.84187029 |
| 83 | MP0005499_abnormal_olfactory_system | 0.83907196 |
| 84 | MP0005394_taste/olfaction_phenotype | 0.83907196 |
| 85 | MP0001958_emphysema | 0.83483630 |
| 86 | MP0008874_decreased_physiological_sensi | 0.83066040 |
| 87 | MP0004085_abnormal_heartbeat | 0.82365427 |
| 88 | MP0008872_abnormal_physiological_respon | 0.81904834 |
| 89 | MP0009764_decreased_sensitivity_to | 0.79624305 |
| 90 | MP0000470_abnormal_stomach_morphology | 0.79602616 |
| 91 | MP0004215_abnormal_myocardial_fiber | 0.78439945 |
| 92 | MP0002090_abnormal_vision | 0.78049122 |
| 93 | MP0001986_abnormal_taste_sensitivity | 0.78038877 |
| 94 | MP0000569_abnormal_digit_pigmentation | 0.75577009 |
| 95 | MP0001188_hyperpigmentation | 0.75391025 |
| 96 | MP0010386_abnormal_urinary_bladder | 0.75266593 |
| 97 | MP0002837_dystrophic_cardiac_calcinosis | 0.75162397 |
| 98 | MP0003638_abnormal_response/metabolism_ | 0.75071657 |
| 99 | MP0006072_abnormal_retinal_apoptosis | 0.74907786 |
| 100 | MP0001963_abnormal_hearing_physiology | 0.74078755 |
| 101 | MP0003718_maternal_effect | 0.73728465 |
| 102 | MP0005253_abnormal_eye_physiology | 0.73524875 |
| 103 | MP0000631_abnormal_neuroendocrine_gland | 0.72384029 |
| 104 | MP0002876_abnormal_thyroid_physiology | 0.71107227 |
| 105 | MP0003137_abnormal_impulse_conducting | 0.70520040 |
| 106 | MP0005535_abnormal_body_temperature | 0.69898552 |
| 107 | MP0004145_abnormal_muscle_electrophysio | 0.69200852 |
| 108 | MP0001348_abnormal_lacrimal_gland | 0.69030454 |
| 109 | MP0003953_abnormal_hormone_level | 0.67782612 |
| 110 | MP0002693_abnormal_pancreas_physiology | 0.67168483 |
| 111 | MP0004484_altered_response_of | 0.66738624 |
| 112 | MP0003861_abnormal_nervous_system | 0.66682526 |
| 113 | MP0004742_abnormal_vestibular_system | 0.66137272 |
| 114 | MP0002078_abnormal_glucose_homeostasis | 0.65699777 |
| 115 | MP0000920_abnormal_myelination | 0.65574924 |
| 116 | MP0004233_abnormal_muscle_weight | 0.62082214 |
| 117 | MP0002638_abnormal_pupillary_reflex | 0.60699334 |
| 118 | MP0005623_abnormal_meninges_morphology | 0.58365418 |
| 119 | MP0000465_gastrointestinal_hemorrhage | 0.57236658 |
| 120 | MP0005187_abnormal_penis_morphology | 0.56952669 |
| 121 | MP0004130_abnormal_muscle_cell | 0.55604077 |
| 122 | MP0010769_abnormal_survival | 0.54344351 |
| 123 | MP0001299_abnormal_eye_distance/ | 0.53142976 |
| 124 | MP0008875_abnormal_xenobiotic_pharmacok | 0.51296372 |
| 125 | MP0002089_abnormal_postnatal_growth/wei | 0.51167079 |
| 126 | MP0002082_postnatal_lethality | 0.51023749 |
| 127 | MP0010770_preweaning_lethality | 0.51023749 |
| 128 | MP0004019_abnormal_vitamin_homeostasis | 0.46880830 |
| 129 | MP0003866_abnormal_defecation | 0.45381285 |
| 130 | MP0001915_intracranial_hemorrhage | 0.41811837 |
| 131 | MP0002098_abnormal_vibrissa_morphology | 0.39547105 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 9.46160402 |
| 2 | Abnormality of dental color (HP:0011073) | 7.42681964 |
| 3 | Abnormality of renal resorption (HP:0011038) | 7.25857675 |
| 4 | Osteomalacia (HP:0002749) | 7.20101798 |
| 5 | Focal motor seizures (HP:0011153) | 7.12219747 |
| 6 | Myokymia (HP:0002411) | 7.06706431 |
| 7 | Abnormality of the dental pulp (HP:0006479) | 6.83783807 |
| 8 | Polyuria (HP:0000103) | 6.70982095 |
| 9 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 5.71485091 |
| 10 | Abnormal urine output (HP:0012590) | 5.71377877 |
| 11 | Visual hallucinations (HP:0002367) | 5.49991850 |
| 12 | Focal seizures (HP:0007359) | 5.34322828 |
| 13 | Abnormality of renal excretion (HP:0011036) | 4.98624085 |
| 14 | Epileptic encephalopathy (HP:0200134) | 4.76092813 |
| 15 | Round ear (HP:0100830) | 4.71463054 |
| 16 | Chronic bronchitis (HP:0004469) | 4.11457913 |
| 17 | Progressive cerebellar ataxia (HP:0002073) | 4.08783067 |
| 18 | Supranuclear gaze palsy (HP:0000605) | 4.07722204 |
| 19 | Febrile seizures (HP:0002373) | 4.06406790 |
| 20 | Volvulus (HP:0002580) | 3.86885683 |
| 21 | Atonic seizures (HP:0010819) | 3.74781476 |
| 22 | Mutism (HP:0002300) | 3.72792013 |
| 23 | Action tremor (HP:0002345) | 3.71434813 |
| 24 | Absence seizures (HP:0002121) | 3.64677912 |
| 25 | Generalized tonic-clonic seizures (HP:0002069) | 3.59037162 |
| 26 | Abnormality of midbrain morphology (HP:0002418) | 3.56965753 |
| 27 | Molar tooth sign on MRI (HP:0002419) | 3.56965753 |
| 28 | Nephrocalcinosis (HP:0000121) | 3.53210693 |
| 29 | Ankle clonus (HP:0011448) | 3.52593071 |
| 30 | Poor eye contact (HP:0000817) | 3.46290511 |
| 31 | Broad-based gait (HP:0002136) | 3.44194862 |
| 32 | Dialeptic seizures (HP:0011146) | 3.35951930 |
| 33 | Lip pit (HP:0100267) | 3.31609790 |
| 34 | Papilledema (HP:0001085) | 3.30967655 |
| 35 | Autoimmune thrombocytopenia (HP:0001973) | 3.28157016 |
| 36 | IgM deficiency (HP:0002850) | 3.27790048 |
| 37 | Depression (HP:0000716) | 3.25687181 |
| 38 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.25092583 |
| 39 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.22414567 |
| 40 | Toxemia of pregnancy (HP:0100603) | 3.17520207 |
| 41 | Tachypnea (HP:0002789) | 3.16341323 |
| 42 | Neurofibrillary tangles (HP:0002185) | 3.13836643 |
| 43 | Depressed nasal tip (HP:0000437) | 3.11930158 |
| 44 | Abnormal social behavior (HP:0012433) | 3.07757176 |
| 45 | Impaired social interactions (HP:0000735) | 3.07757176 |
| 46 | Amblyopia (HP:0000646) | 3.07629863 |
| 47 | Cerebral inclusion bodies (HP:0100314) | 3.06415049 |
| 48 | Esophageal varix (HP:0002040) | 2.98554514 |
| 49 | Large earlobe (HP:0009748) | 2.96653027 |
| 50 | Dysdiadochokinesis (HP:0002075) | 2.91438184 |
| 51 | Abnormal eating behavior (HP:0100738) | 2.91177685 |
| 52 | Personality changes (HP:0000751) | 2.90884971 |
| 53 | Abnormality of the lower motor neuron (HP:0002366) | 2.90872708 |
| 54 | Genetic anticipation (HP:0003743) | 2.86832805 |
| 55 | Postural instability (HP:0002172) | 2.85862716 |
| 56 | Gaze-evoked nystagmus (HP:0000640) | 2.82885184 |
| 57 | Hyperventilation (HP:0002883) | 2.82842013 |
| 58 | Drooling (HP:0002307) | 2.81067817 |
| 59 | Excessive salivation (HP:0003781) | 2.81067817 |
| 60 | Abnormality of binocular vision (HP:0011514) | 2.75772232 |
| 61 | Diplopia (HP:0000651) | 2.75772232 |
| 62 | Anxiety (HP:0000739) | 2.74709706 |
| 63 | Truncal ataxia (HP:0002078) | 2.74077054 |
| 64 | Hypoparathyroidism (HP:0000829) | 2.73607861 |
| 65 | Dysmetria (HP:0001310) | 2.73553734 |
| 66 | Megalencephaly (HP:0001355) | 2.73397585 |
| 67 | Hyperphosphaturia (HP:0003109) | 2.73218053 |
| 68 | Rhinitis (HP:0012384) | 2.69870655 |
| 69 | Abnormality of the corticospinal tract (HP:0002492) | 2.69508932 |
| 70 | Urinary urgency (HP:0000012) | 2.66539420 |
| 71 | Hemiparesis (HP:0001269) | 2.65899091 |
| 72 | Amyotrophic lateral sclerosis (HP:0007354) | 2.64521443 |
| 73 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.63869069 |
| 74 | Spastic gait (HP:0002064) | 2.63267811 |
| 75 | Thick eyebrow (HP:0000574) | 2.62958222 |
| 76 | Torticollis (HP:0000473) | 2.61841286 |
| 77 | Lipoatrophy (HP:0100578) | 2.61646176 |
| 78 | Sparse lateral eyebrow (HP:0005338) | 2.60878962 |
| 79 | Bradykinesia (HP:0002067) | 2.58254339 |
| 80 | Stereotypic behavior (HP:0000733) | 2.55480510 |
| 81 | Epileptiform EEG discharges (HP:0011182) | 2.54398883 |
| 82 | Intention tremor (HP:0002080) | 2.51759656 |
| 83 | Nephronophthisis (HP:0000090) | 2.50484574 |
| 84 | Hemiplegia (HP:0002301) | 2.50071629 |
| 85 | Insidious onset (HP:0003587) | 2.48963412 |
| 86 | Termporal pattern (HP:0011008) | 2.48963412 |
| 87 | Focal dystonia (HP:0004373) | 2.48861805 |
| 88 | Akinesia (HP:0002304) | 2.46067927 |
| 89 | EEG with generalized epileptiform discharges (HP:0011198) | 2.45395491 |
| 90 | Obstructive sleep apnea (HP:0002870) | 2.43192283 |
| 91 | Impaired smooth pursuit (HP:0007772) | 2.42262659 |
| 92 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.40098093 |
| 93 | Aplasia of the phalanges of the hand (HP:0009802) | 2.40098093 |
| 94 | Aplasia involving bones of the extremities (HP:0009825) | 2.40098093 |
| 95 | Intestinal fistula (HP:0100819) | 2.39265508 |
| 96 | Polyphagia (HP:0002591) | 2.38377637 |
| 97 | Hypsarrhythmia (HP:0002521) | 2.36648087 |
| 98 | Ventricular fibrillation (HP:0001663) | 2.34472184 |
| 99 | Abnormal urine phosphate concentration (HP:0012599) | 2.29173502 |
| 100 | Lower limb muscle weakness (HP:0007340) | 2.28997132 |
| 101 | Hypercalciuria (HP:0002150) | 2.25766841 |
| 102 | Panhypogammaglobulinemia (HP:0003139) | 2.24534613 |
| 103 | Apathy (HP:0000741) | 2.22124944 |
| 104 | Insomnia (HP:0100785) | 2.20145957 |
| 105 | Fetal akinesia sequence (HP:0001989) | 2.19675313 |
| 106 | Craniofacial dystonia (HP:0012179) | 2.19643384 |
| 107 | Agitation (HP:0000713) | 2.18871908 |
| 108 | Progressive inability to walk (HP:0002505) | 2.18695290 |
| 109 | Nephropathy (HP:0000112) | 2.17941470 |
| 110 | Sudden cardiac death (HP:0001645) | 2.17387735 |
| 111 | Limb dystonia (HP:0002451) | 2.16493074 |
| 112 | Absent speech (HP:0001344) | 2.15262584 |
| 113 | Hepatitis (HP:0012115) | 2.14642637 |
| 114 | Inappropriate behavior (HP:0000719) | 2.14220165 |
| 115 | Striae distensae (HP:0001065) | 2.14012903 |
| 116 | Impaired vibratory sensation (HP:0002495) | 2.13006157 |
| 117 | Chorioretinal coloboma (HP:0000567) | 2.11470590 |
| 118 | Inability to walk (HP:0002540) | 2.10213595 |
| 119 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.08049620 |
| 120 | Decreased muscle mass (HP:0003199) | 2.07956085 |
| 121 | Short 5th finger (HP:0009237) | 2.04857338 |
| 122 | Pointed chin (HP:0000307) | 2.02920045 |
| 123 | Ureteral stenosis (HP:0000071) | 2.02444270 |
| 124 | Generalized myoclonic seizures (HP:0002123) | 2.01798227 |
| 125 | Overgrowth (HP:0001548) | 10.9336422 |
| 126 | Amelogenesis imperfecta (HP:0000705) | 10.3266231 |
| 127 | Prominent supraorbital ridges (HP:0000336) | 1.99915217 |
| 128 | Scanning speech (HP:0002168) | 1.99701701 |
| 129 | Rapidly progressive (HP:0003678) | 1.97660745 |
| 130 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.97558813 |
| 131 | Ankyloglossia (HP:0010296) | 1.96627022 |
| 132 | Central scotoma (HP:0000603) | 1.96514757 |
| 133 | Dilated cardiomyopathy (HP:0001644) | 1.96114534 |
| 134 | Diminished motivation (HP:0000745) | 1.93819440 |
| 135 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.92815979 |
| 136 | Hypoplasia of the brainstem (HP:0002365) | 1.92815979 |
| 137 | Neuronal loss in central nervous system (HP:0002529) | 1.92528246 |
| 138 | Status epilepticus (HP:0002133) | 1.92349764 |
| 139 | Bundle branch block (HP:0011710) | 1.89383117 |
| 140 | Annular pancreas (HP:0001734) | 1.89354811 |
| 141 | Dyschromatopsia (HP:0007641) | 1.86990700 |
| 142 | Preauricular pit (HP:0004467) | 1.86672956 |
| 143 | Periauricular skin pits (HP:0100277) | 1.86672956 |
| 144 | Abnormal EKG (HP:0003115) | 1.86562213 |
| 145 | Lower limb amyotrophy (HP:0007210) | 1.85849520 |
| 146 | Incomplete penetrance (HP:0003829) | 1.85424881 |
| 147 | Lower limb asymmetry (HP:0100559) | 1.84061032 |
| 148 | Abnormality of salivation (HP:0100755) | 1.83178331 |
| 149 | Ureteral obstruction (HP:0006000) | 1.82717745 |
| 150 | Agammaglobulinemia (HP:0004432) | 1.82694101 |
| 151 | Glycosuria (HP:0003076) | 1.82100603 |
| 152 | Abnormality of urine glucose concentration (HP:0011016) | 1.82100603 |
| 153 | Colitis (HP:0002583) | 1.81110897 |
| 154 | Intellectual disability, profound (HP:0002187) | 1.80450371 |
| 155 | Rigidity (HP:0002063) | 1.79367549 |
| 156 | Delusions (HP:0000746) | 1.77578457 |
| 157 | Gingival overgrowth (HP:0000212) | 1.76962532 |
| 158 | Abnormality of the fingertips (HP:0001211) | 1.76795266 |
| 159 | Abnormality of the renal medulla (HP:0100957) | 1.73841235 |
| 160 | Recurrent otitis media (HP:0000403) | 1.73049786 |
| 161 | Delayed eruption of teeth (HP:0000684) | 1.70886721 |
| 162 | Petechiae (HP:0000967) | 1.69616631 |
| 163 | Mask-like facies (HP:0000298) | 1.66880129 |
| 164 | Open mouth (HP:0000194) | 1.65674507 |
| 165 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.62581286 |
| 166 | Villous atrophy (HP:0011473) | 1.62581286 |
| 167 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.61393428 |
| 168 | Renal tubular dysfunction (HP:0000124) | 1.55934704 |
| 169 | Preauricular skin tag (HP:0000384) | 1.52227482 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.73643713 |
| 2 | MARK1 | 4.66100592 |
| 3 | MAP4K1 | 4.36721617 |
| 4 | EPHA4 | 4.33536606 |
| 5 | MAP3K9 | 3.87507889 |
| 6 | BLK | 3.31787583 |
| 7 | STK3 | 3.05633583 |
| 8 | MINK1 | 2.89902445 |
| 9 | MAP3K4 | 2.83796217 |
| 10 | PAK6 | 2.45629569 |
| 11 | DAPK2 | 2.42914554 |
| 12 | MAP2K7 | 2.31767780 |
| 13 | NTRK2 | 2.12761140 |
| 14 | PRKD3 | 2.07951471 |
| 15 | KSR2 | 2.07462754 |
| 16 | CAMKK1 | 1.80981264 |
| 17 | NTRK1 | 1.73901625 |
| 18 | KSR1 | 1.72856739 |
| 19 | SIK2 | 1.71911272 |
| 20 | MAP2K4 | 1.66545009 |
| 21 | PHKG2 | 1.61233310 |
| 22 | PHKG1 | 1.61233310 |
| 23 | CDK5 | 1.57983178 |
| 24 | MAP3K12 | 1.56573326 |
| 25 | MAPK13 | 1.55413124 |
| 26 | LATS2 | 1.47240345 |
| 27 | DAPK1 | 1.45279561 |
| 28 | TNIK | 1.40185322 |
| 29 | CDK19 | 1.38234664 |
| 30 | PLK2 | 1.35040176 |
| 31 | STK38 | 1.35023616 |
| 32 | FES | 1.28919890 |
| 33 | CASK | 1.28734794 |
| 34 | PRKCG | 1.25739751 |
| 35 | GRK5 | 1.25493976 |
| 36 | PRPF4B | 1.23623007 |
| 37 | TAOK1 | 1.06935930 |
| 38 | RIPK4 | 1.06812240 |
| 39 | MAP3K2 | 1.05809640 |
| 40 | TYRO3 | 1.01204645 |
| 41 | UHMK1 | 0.96980575 |
| 42 | HIPK2 | 0.93854508 |
| 43 | DYRK1A | 0.93548980 |
| 44 | MAP3K13 | 0.92343736 |
| 45 | CDK18 | 0.91564851 |
| 46 | CDK15 | 0.91342421 |
| 47 | CAMK2A | 0.90371370 |
| 48 | PAK3 | 0.89537667 |
| 49 | LMTK2 | 0.87091991 |
| 50 | ARAF | 0.86630891 |
| 51 | CAMK1 | 0.86285886 |
| 52 | CDK14 | 0.86234033 |
| 53 | STK11 | 0.85825983 |
| 54 | MAP4K2 | 0.84435992 |
| 55 | PNCK | 0.83678130 |
| 56 | RET | 0.82821685 |
| 57 | SGK223 | 0.81789123 |
| 58 | SGK494 | 0.81789123 |
| 59 | CCNB1 | 0.81667736 |
| 60 | CDK11A | 0.80682484 |
| 61 | MARK2 | 0.78431873 |
| 62 | INSRR | 0.77363127 |
| 63 | ALK | 0.76356362 |
| 64 | PRKCH | 0.75710996 |
| 65 | CSNK1G2 | 0.72839593 |
| 66 | SGK2 | 0.71864205 |
| 67 | RAF1 | 0.69897079 |
| 68 | ROCK2 | 0.68863289 |
| 69 | CAMK2B | 0.66929094 |
| 70 | SGK1 | 0.66790235 |
| 71 | PINK1 | 0.66605255 |
| 72 | SGK3 | 0.64707616 |
| 73 | WNK3 | 0.64338065 |
| 74 | PRKCZ | 0.63599158 |
| 75 | SRC | 0.63137799 |
| 76 | FGFR1 | 0.63077548 |
| 77 | PRKAA1 | 0.62428903 |
| 78 | ERBB3 | 0.61673362 |
| 79 | MAP3K6 | 0.61658237 |
| 80 | PDK1 | 0.59974265 |
| 81 | SYK | 0.55884718 |
| 82 | PTK2B | 0.55183123 |
| 83 | FER | 0.55025683 |
| 84 | OXSR1 | 0.54652432 |
| 85 | MAPK12 | 0.54379148 |
| 86 | SCYL2 | 0.53998579 |
| 87 | PDPK1 | 0.50899548 |
| 88 | DYRK2 | 0.49554416 |
| 89 | MAP3K7 | 0.49227572 |
| 90 | PRKACG | 0.46728278 |
| 91 | RPS6KA2 | 0.46529118 |
| 92 | RPS6KA3 | 0.45447926 |
| 93 | PRKCQ | 0.45134414 |
| 94 | MAP2K6 | 0.45125872 |
| 95 | PKN1 | 0.44225456 |
| 96 | CDC42BPA | 0.44185666 |
| 97 | NEK1 | 0.44135111 |
| 98 | PRKACA | 0.44025207 |
| 99 | PRKCE | 0.43558450 |
| 100 | FYN | 0.43139656 |
| 101 | CAMKK2 | 0.43124269 |
| 102 | ROCK1 | 0.40401245 |
| 103 | PRKACB | 0.39160580 |
| 104 | NME1 | 0.37720744 |
| 105 | DAPK3 | 0.37206628 |
| 106 | CAMK1G | 0.37000100 |
| 107 | MAP3K1 | 0.35564701 |
| 108 | CAMK2D | 0.35062165 |
| 109 | FGR | 0.34121578 |
| 110 | PRKCA | 0.33939607 |
| 111 | MAPK10 | 0.33423634 |
| 112 | CAMK4 | 0.32950360 |
| 113 | PRKCB | 0.32175622 |
| 114 | CAMK2G | 0.32087893 |
| 115 | TAOK2 | 0.31877819 |
| 116 | BMPR2 | 0.31494777 |
| 117 | MAP2K1 | 0.30969895 |
| 118 | RIPK1 | 0.30677356 |
| 119 | NEK6 | 0.29980913 |
| 120 | GSK3B | 0.29140136 |
| 121 | GRK7 | 0.28577220 |
| 122 | OBSCN | 0.27980708 |
| 123 | CSNK1A1 | 0.25921946 |
| 124 | MUSK | 0.25297696 |
| 125 | MAPKAPK5 | 0.24441308 |
| 126 | ABL1 | 0.24066773 |
| 127 | MAPK14 | 0.22503417 |
| 128 | MAPK9 | 0.18808136 |
| 129 | PRKDC | 0.18732358 |
| 130 | MAPK15 | 0.16683002 |
| 131 | TIE1 | 0.16517064 |
| 132 | SRPK1 | 0.16230227 |
| 133 | PRKCD | 0.15379591 |
| 134 | GRK1 | 0.12820837 |
| 135 | CDK1 | 0.11344647 |
| 136 | ADRBK2 | 0.09949250 |
| 137 | ERBB2 | 0.08985182 |
| 138 | CSNK1D | 0.08657281 |
| 139 | EPHA3 | 0.08348996 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Tuberculosis_Homo sapiens_hsa05152 | 6.08166777 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.59053360 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.27618575 |
| 4 | Sulfur relay system_Homo sapiens_hsa04122 | 3.04479445 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.73262557 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.70113333 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.64970685 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.63110941 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.61681721 |
| 10 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.55206941 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.53298974 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 2.42376134 |
| 13 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.36592149 |
| 14 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.30701350 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.27924143 |
| 16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.10224299 |
| 17 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.09023847 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 2.05598735 |
| 19 | Phototransduction_Homo sapiens_hsa04744 | 2.01593663 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.98711924 |
| 21 | Insulin secretion_Homo sapiens_hsa04911 | 1.97551893 |
| 22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.87432810 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.83181470 |
| 24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.65881699 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.65631398 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.63257390 |
| 27 | Long-term depression_Homo sapiens_hsa04730 | 1.58456622 |
| 28 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.55238303 |
| 29 | Renin secretion_Homo sapiens_hsa04924 | 1.54461547 |
| 30 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.53425620 |
| 31 | Cocaine addiction_Homo sapiens_hsa05030 | 1.53219019 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.48974432 |
| 33 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.44173008 |
| 34 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.43793188 |
| 35 | Axon guidance_Homo sapiens_hsa04360 | 1.39976304 |
| 36 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.39195661 |
| 37 | Gap junction_Homo sapiens_hsa04540 | 1.36017815 |
| 38 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.31171576 |
| 39 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.28846386 |
| 40 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.28090789 |
| 41 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.26930120 |
| 42 | Glioma_Homo sapiens_hsa05214 | 1.25574068 |
| 43 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.23498518 |
| 44 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.21016867 |
| 45 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.16182642 |
| 46 | Melanogenesis_Homo sapiens_hsa04916 | 1.06830936 |
| 47 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.04319147 |
| 48 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.03491926 |
| 49 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.03351983 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.03166221 |
| 51 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.02937925 |
| 52 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01530229 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.00904600 |
| 54 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.90331710 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.85517153 |
| 56 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85474459 |
| 57 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.84572008 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.84119991 |
| 59 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.84020381 |
| 60 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.79225487 |
| 61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.78041553 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.77413836 |
| 63 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77066062 |
| 64 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.76736120 |
| 65 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76231928 |
| 66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72879662 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72394257 |
| 68 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72102765 |
| 69 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.71389971 |
| 70 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.70016542 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.69529572 |
| 72 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.68104068 |
| 73 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.67724403 |
| 74 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.66901334 |
| 75 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65799269 |
| 76 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64976176 |
| 77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60821704 |
| 78 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59845444 |
| 79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58141528 |
| 80 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57960096 |
| 81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57932513 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57806327 |
| 83 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55530137 |
| 84 | Circadian rhythm_Homo sapiens_hsa04710 | 0.54049608 |
| 85 | Bile secretion_Homo sapiens_hsa04976 | 0.52334109 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.51740879 |
| 87 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.51266312 |
| 88 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.50680248 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50397970 |
| 90 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.49145268 |
| 91 | Prion diseases_Homo sapiens_hsa05020 | 0.47485581 |
| 92 | Alcoholism_Homo sapiens_hsa05034 | 0.45105376 |
| 93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43964992 |
| 94 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43714484 |
| 95 | Colorectal cancer_Homo sapiens_hsa05210 | 0.43608968 |
| 96 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.43396838 |
| 97 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42659628 |
| 98 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.42200919 |
| 99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39993499 |
| 100 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.39688047 |
| 101 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.37703704 |
| 102 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.37317682 |
| 103 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.36429296 |
| 104 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.36217287 |
| 105 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.36133844 |
| 106 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.33994450 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31652009 |
| 108 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.30437772 |
| 109 | Parkinsons disease_Homo sapiens_hsa05012 | 0.29375899 |
| 110 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.28995267 |
| 111 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.27119769 |
| 112 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.25598743 |
| 113 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.25030169 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24259160 |
| 115 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.24030370 |
| 116 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.23994404 |
| 117 | RNA degradation_Homo sapiens_hsa03018 | 0.23254688 |
| 118 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.19587787 |
| 119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.14428520 |
| 120 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.13267192 |
| 121 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.11847017 |
| 122 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.10336152 |
| 123 | Phagosome_Homo sapiens_hsa04145 | 0.07609416 |
| 124 | Purine metabolism_Homo sapiens_hsa00230 | 0.06672596 |
| 125 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.04500715 |
| 126 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.00570242 |
| 127 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | -0.0383669 |
| 128 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | -0.0116923 |
| 129 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0074904 |

